Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production.

Kozicky, Lisa K

Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production. [electronic resource] - European journal of immunology 08 2019 - 1251-1268 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1521-4141

10.1002/eji.201848014 doi


Adoptive Transfer
Animals
Cell Differentiation
Cells, Cultured
Colitis--chemically induced
Colon--metabolism
Dextran Sulfate
Disease Models, Animal
Humans
Immunoglobulins, Intravenous--therapeutic use
Inflammation Mediators--metabolism
Inflammatory Bowel Diseases--drug therapy
Interleukin-10--genetics
Macrophages--drug effects
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Knockout